ALLOGENEIC TRANSPLANTATION

Read 1335 times

1.GRAVITAS-301: GRAVITAS-301: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease

Study Locations in Greece:

General Hospital of Thessaloniki G. Papanikolaou - Hematology Department

University General Hospital of Patras

University Hospital of West Attica - Attikon - Hematology Division, Athens (Not yet recruiting)

2. Protocol Nο.:2215-CL-0304 A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Trial of the FLT3 Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/ITD AM

Study Locations in Greece:

General Hospital of Thessaloniki G. Papanikolaou - Hematology Department

University General Hospital of Patras